vs
Side-by-side financial comparison of AVANOS MEDICAL, INC. (AVNS) and CARRIAGE SERVICES INC (CSV). Click either name above to swap in a different company.
AVANOS MEDICAL, INC. is the larger business by last-quarter revenue ($180.9M vs $105.5M, roughly 1.7× CARRIAGE SERVICES INC). CARRIAGE SERVICES INC runs the higher net margin — 11.6% vs -0.7%, a 12.4% gap on every dollar of revenue. On growth, CARRIAGE SERVICES INC posted the faster year-over-year revenue change (8.0% vs 0.7%). AVANOS MEDICAL, INC. produced more free cash flow last quarter ($21.3M vs $6.2M). Over the past eight quarters, AVANOS MEDICAL, INC.'s revenue compounded faster (4.4% CAGR vs 1.0%).
Avanos Medical, Inc. is a medical technology company making clinical medical devices. The company consists of two franchises – Pain Management and Chronic Care – that address reducing the use of opioids while helping patients recover faster and preventing infection.
Jardine Cycle & Carriage Limited is the investment holding company of Jardines in Southeast Asia. It is currently 75% held by the conglomerate.
AVNS vs CSV — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $180.9M | $105.5M |
| Net Profit | $-1.3M | $12.3M |
| Gross Margin | 47.5% | 34.8% |
| Operating Margin | 1.4% | 23.3% |
| Net Margin | -0.7% | 11.6% |
| Revenue YoY | 0.7% | 8.0% |
| Net Profit YoY | 99.7% | 24.5% |
| EPS (diluted) | $-0.02 | $0.76 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $180.9M | $105.5M | ||
| Q3 25 | $177.8M | $102.7M | ||
| Q2 25 | $175.0M | $102.1M | ||
| Q1 25 | $167.5M | $107.1M | ||
| Q4 24 | $179.6M | $97.7M | ||
| Q3 24 | $170.4M | $100.7M | ||
| Q2 24 | $171.7M | $102.3M | ||
| Q1 24 | $166.1M | $103.5M |
| Q4 25 | $-1.3M | $12.3M | ||
| Q3 25 | $-1.4M | $6.6M | ||
| Q2 25 | $-76.8M | $11.7M | ||
| Q1 25 | $6.6M | $20.9M | ||
| Q4 24 | $-397.3M | $9.9M | ||
| Q3 24 | $4.3M | $9.9M | ||
| Q2 24 | $1.8M | $6.3M | ||
| Q1 24 | $-900.0K | $7.0M |
| Q4 25 | 47.5% | 34.8% | ||
| Q3 25 | 48.4% | 35.3% | ||
| Q2 25 | 52.6% | 35.2% | ||
| Q1 25 | 53.6% | 35.3% | ||
| Q4 24 | 54.6% | 34.4% | ||
| Q3 24 | 54.5% | 35.2% | ||
| Q2 24 | 55.7% | 36.2% | ||
| Q1 24 | 57.1% | 36.0% |
| Q4 25 | 1.4% | 23.3% | ||
| Q3 25 | 0.1% | 17.0% | ||
| Q2 25 | -42.6% | 23.5% | ||
| Q1 25 | 6.1% | 29.5% | ||
| Q4 24 | -233.0% | 21.6% | ||
| Q3 24 | 7.0% | 22.7% | ||
| Q2 24 | 3.7% | 18.0% | ||
| Q1 24 | 2.4% | 18.8% |
| Q4 25 | -0.7% | 11.6% | ||
| Q3 25 | -0.8% | 6.4% | ||
| Q2 25 | -43.9% | 11.5% | ||
| Q1 25 | 3.9% | 19.5% | ||
| Q4 24 | -221.2% | 10.1% | ||
| Q3 24 | 2.5% | 9.8% | ||
| Q2 24 | 1.0% | 6.1% | ||
| Q1 24 | -0.5% | 6.7% |
| Q4 25 | $-0.02 | $0.76 | ||
| Q3 25 | $-0.03 | $0.41 | ||
| Q2 25 | $-1.66 | $0.74 | ||
| Q1 25 | $0.14 | $1.34 | ||
| Q4 24 | $-8.64 | $0.62 | ||
| Q3 24 | $0.09 | $0.63 | ||
| Q2 24 | $0.04 | $0.40 | ||
| Q1 24 | $-0.02 | $0.45 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $89.8M | $1.7M |
| Total DebtLower is stronger | $90.3M | — |
| Stockholders' EquityBook value | $778.2M | $254.8M |
| Total Assets | $1.1B | $1.3B |
| Debt / EquityLower = less leverage | 0.12× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $89.8M | $1.7M | ||
| Q3 25 | $70.5M | $1.2M | ||
| Q2 25 | $90.3M | $1.4M | ||
| Q1 25 | $97.0M | $4.6M | ||
| Q4 24 | $107.7M | $1.2M | ||
| Q3 24 | $89.0M | $1.3M | ||
| Q2 24 | $92.2M | $1.5M | ||
| Q1 24 | $75.8M | $1.7M |
| Q4 25 | $90.3M | — | ||
| Q3 25 | $93.4M | — | ||
| Q2 25 | $95.7M | — | ||
| Q1 25 | $98.0M | — | ||
| Q4 24 | $125.3M | — | ||
| Q3 24 | $152.6M | — | ||
| Q2 24 | $164.9M | — | ||
| Q1 24 | $167.2M | — |
| Q4 25 | $778.2M | $254.8M | ||
| Q3 25 | $778.0M | $242.1M | ||
| Q2 25 | $776.3M | $235.4M | ||
| Q1 25 | $839.4M | $223.1M | ||
| Q4 24 | $828.5M | $208.6M | ||
| Q3 24 | $1.2B | $198.1M | ||
| Q2 24 | $1.2B | $187.9M | ||
| Q1 24 | $1.2B | $179.6M |
| Q4 25 | $1.1B | $1.3B | ||
| Q3 25 | $1.1B | $1.3B | ||
| Q2 25 | $1.0B | $1.3B | ||
| Q1 25 | $1.1B | $1.3B | ||
| Q4 24 | $1.2B | $1.3B | ||
| Q3 24 | $1.7B | $1.3B | ||
| Q2 24 | $1.7B | $1.3B | ||
| Q1 24 | $1.7B | $1.3B |
| Q4 25 | 0.12× | — | ||
| Q3 25 | 0.12× | — | ||
| Q2 25 | 0.12× | — | ||
| Q1 25 | 0.12× | — | ||
| Q4 24 | 0.15× | — | ||
| Q3 24 | 0.12× | — | ||
| Q2 24 | 0.13× | — | ||
| Q1 24 | 0.14× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $28.2M | $14.1M |
| Free Cash FlowOCF − Capex | $21.3M | $6.2M |
| FCF MarginFCF / Revenue | 11.8% | 5.9% |
| Capex IntensityCapex / Revenue | 3.8% | 7.5% |
| Cash ConversionOCF / Net Profit | — | 1.15× |
| TTM Free Cash FlowTrailing 4 quarters | $43.1M | $40.1M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $28.2M | $14.1M | ||
| Q3 25 | $14.0M | $24.7M | ||
| Q2 25 | $6.8M | $8.1M | ||
| Q1 25 | $25.7M | $13.8M | ||
| Q4 24 | $57.9M | $9.3M | ||
| Q3 24 | $23.0M | $20.9M | ||
| Q2 24 | $27.8M | $2.2M | ||
| Q1 24 | $-8.0M | $19.7M |
| Q4 25 | $21.3M | $6.2M | ||
| Q3 25 | $7.0M | $18.0M | ||
| Q2 25 | $-4.2M | $5.2M | ||
| Q1 25 | $19.0M | $10.6M | ||
| Q4 24 | $53.1M | $4.9M | ||
| Q3 24 | $20.0M | $16.2M | ||
| Q2 24 | $21.9M | $-1.4M | ||
| Q1 24 | $-12.1M | $16.2M |
| Q4 25 | 11.8% | 5.9% | ||
| Q3 25 | 3.9% | 17.5% | ||
| Q2 25 | -2.4% | 5.1% | ||
| Q1 25 | 11.3% | 9.9% | ||
| Q4 24 | 29.6% | 5.0% | ||
| Q3 24 | 11.7% | 16.1% | ||
| Q2 24 | 12.8% | -1.4% | ||
| Q1 24 | -7.3% | 15.6% |
| Q4 25 | 3.8% | 7.5% | ||
| Q3 25 | 3.9% | 6.5% | ||
| Q2 25 | 6.3% | 2.8% | ||
| Q1 25 | 4.0% | 3.0% | ||
| Q4 24 | 2.7% | 4.5% | ||
| Q3 24 | 1.8% | 4.6% | ||
| Q2 24 | 3.4% | 3.5% | ||
| Q1 24 | 2.5% | 3.4% |
| Q4 25 | — | 1.15× | ||
| Q3 25 | — | 3.76× | ||
| Q2 25 | — | 0.69× | ||
| Q1 25 | 3.89× | 0.66× | ||
| Q4 24 | — | 0.94× | ||
| Q3 24 | 5.35× | 2.11× | ||
| Q2 24 | 15.44× | 0.34× | ||
| Q1 24 | — | 2.83× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
AVNS
| Enteral Feeding | $83.0M | 46% |
| Radiofrequency Ablation | $36.9M | 20% |
| Neonate Solutions | $32.1M | 18% |
| Surgical Pain And Recovery | $24.7M | 14% |
| Corporate Other | $4.2M | 2% |
CSV
| Propertyand Merchandise | $47.8M | 45% |
| Cemetery Interment Rights | $24.8M | 23% |
| Merchandise | $18.9M | 18% |
| Other Revenue | $10.2M | 10% |
| Other | $3.9M | 4% |
